Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1982-2-25
|
pubmed:abstractText |
To determine whether the complete correction of hyperglycemia of diabetes can rapidly improve abnormal peripheral nerve function, eight hyperglycemic insulin-requiring diabetics underwent 3 days of glucose control with an artificial endocrine pancreas, the BIOSTATOR Glucose Controller. Comparison of neurologic assessment before and after BIOSTATOR treatment showed improvement only in ulnar sensory conduction velocity (+ 3.2 +/- 1.4 meters per second, p less than 0.032) and no significant changes in 24 other nerve conduction measurements, computer-assisted examination, and scored neurologic assessment. Any significant beneficial effect on nerve function resulting from correction of hyperglycemia probably requires more than 3 days to be manifested.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0028-3878
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1375-80
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7031500-Adolescent,
pubmed-meshheading:7031500-Adult,
pubmed-meshheading:7031500-Blood Glucose,
pubmed-meshheading:7031500-Clinical Trials as Topic,
pubmed-meshheading:7031500-Diabetes Mellitus,
pubmed-meshheading:7031500-Female,
pubmed-meshheading:7031500-Humans,
pubmed-meshheading:7031500-Insulin Infusion Systems,
pubmed-meshheading:7031500-Male,
pubmed-meshheading:7031500-Middle Aged,
pubmed-meshheading:7031500-Neural Conduction,
pubmed-meshheading:7031500-Peripheral Nerves,
pubmed-meshheading:7031500-Sensory Thresholds,
pubmed-meshheading:7031500-Touch
|
pubmed:year |
1981
|
pubmed:articleTitle |
Effect of artificial pancreas treatment on peripheral nerve function in diabetes.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|